Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT01588756
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase
- Phase 1/2
- Enrolled
- 100 participants
- Registry
-
NCT01588756
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT01588756. Non-randomized; no masking; primary purpose diagnostic. Start 2010-10 (actual); primary completion 2015-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)
- Acronym
- AcSDKP-NH2
- Condition
- Healthy
- Condition
- Chronic Kidney Disease
- Intervention (Drug)
- AcSDKP-NH2 inuline
- Intervention (Drug)
- AcSDKP-NH2 Cr-EDTA
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
Record details
- Record id
cardio:ct-nct01588756- Content hash
83d1d26336d28f765148794604d369b1bbf40e4c73e1c75ac673a6ff49d7d57e